Atom | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

Funder: National Institutes of Health

Funding Amounts: Up to $499,000 direct costs per year; total direct costs not to exceed $750,000 over up to 3 years (R61/R33 mechanism).

Summary: Supports development and validation of animal models and ex vivo systems that closely mimic neurological or neuromuscular disorders to advance neurotherapeutic discovery.

Key Information: Clinical trials are not allowed; clear, quantitative milestones for R61/R33 transition are required.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

Sign in to see full grant listing